Comparison of cardiovascular risk calculators in patients with diabetes

SUMMARY OBJECTIVE: Cardiovascular risk stratification is an important clinical practice to estimate the severity of cardiovascular disease in patients with type 2 diabetes. This study aimed to compare the stratification of global cardiovascular risk with the specific risk stratification for patients with type 2 diabetes, seen at specialized outpatient clinics, and to evaluate possible differences in diagnoses and treatments. METHODS: A total of 122 patients with type 2 diabetes treated at two specialized outpatient clinics, from 2017 to 2019, were studied. The cardiovascular risk stratification calculators, global risk score, Cardiovascular Risk Stratification Calculator, and United Kingdom Prospective Diabetes Study-Risk Engine, were used to calculate the risk of death from cardiovascular disease. The agreement between these calculators was analyzed using the kappa index. The indications for the use of statins and acetylsalicylic acid for the group studied were evaluated according to the Brazilian Diabetes Society Guideline. RESULTS: There was a low degree of agreement among the three risk calculators. The global risk score calculator showed insignificant agreement with the Cardiovascular Risk Stratification Calculator (kappa=0.0816; p=0.0671). There was no agreement between the global risk score calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.099), or between the Cardiovascular Risk Stratification Calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.0095). CONCLUSION: The substantial disagreements among the cardiovascular risk calculators may lead to different diagnoses and may consequently influence therapeutic strategies. The findings herein highlight the need for specific validated cardiovascular risk calculators for patients with DM2 that can reliably estimate risk in these individuals.

Saved in:
Bibliographic Details
Main Authors: Ribeiro,Luana Karem, Amorim,Welma Wildes, Cardoso,Igor Thiago Alvin, Vieira,Wester Silva, Kochergin,Clavdia Nicolaevna, Medeiros,Danielle Souto de, Soares,Daniela Arruda, Louzado,José Andrade, Silva,Kelle Oliveira, Cortes,Matheus Lopes, Mistro,Sóstenes, Bezerra,Vanessa Moraes, Oliveira,Marcio Galvão
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300200
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302021000300200
record_format ojs
spelling oai:scielo:S0104-423020210003002002021-08-12Comparison of cardiovascular risk calculators in patients with diabetesRibeiro,Luana KaremAmorim,Welma WildesCardoso,Igor Thiago AlvinVieira,Wester SilvaKochergin,Clavdia NicolaevnaMedeiros,Danielle Souto deSoares,Daniela ArrudaLouzado,José AndradeSilva,Kelle OliveiraCortes,Matheus LopesMistro,SóstenesBezerra,Vanessa MoraesOliveira,Marcio Galvão Diabetes mellitus Cardiovascular diseases Cardiovascular risk SUMMARY OBJECTIVE: Cardiovascular risk stratification is an important clinical practice to estimate the severity of cardiovascular disease in patients with type 2 diabetes. This study aimed to compare the stratification of global cardiovascular risk with the specific risk stratification for patients with type 2 diabetes, seen at specialized outpatient clinics, and to evaluate possible differences in diagnoses and treatments. METHODS: A total of 122 patients with type 2 diabetes treated at two specialized outpatient clinics, from 2017 to 2019, were studied. The cardiovascular risk stratification calculators, global risk score, Cardiovascular Risk Stratification Calculator, and United Kingdom Prospective Diabetes Study-Risk Engine, were used to calculate the risk of death from cardiovascular disease. The agreement between these calculators was analyzed using the kappa index. The indications for the use of statins and acetylsalicylic acid for the group studied were evaluated according to the Brazilian Diabetes Society Guideline. RESULTS: There was a low degree of agreement among the three risk calculators. The global risk score calculator showed insignificant agreement with the Cardiovascular Risk Stratification Calculator (kappa=0.0816; p=0.0671). There was no agreement between the global risk score calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.099), or between the Cardiovascular Risk Stratification Calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.0095). CONCLUSION: The substantial disagreements among the cardiovascular risk calculators may lead to different diagnoses and may consequently influence therapeutic strategies. The findings herein highlight the need for specific validated cardiovascular risk calculators for patients with DM2 that can reliably estimate risk in these individuals.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.67 n.2 20212021-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300200en10.1590/1806-9282.67.02.20200514
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ribeiro,Luana Karem
Amorim,Welma Wildes
Cardoso,Igor Thiago Alvin
Vieira,Wester Silva
Kochergin,Clavdia Nicolaevna
Medeiros,Danielle Souto de
Soares,Daniela Arruda
Louzado,José Andrade
Silva,Kelle Oliveira
Cortes,Matheus Lopes
Mistro,Sóstenes
Bezerra,Vanessa Moraes
Oliveira,Marcio Galvão
spellingShingle Ribeiro,Luana Karem
Amorim,Welma Wildes
Cardoso,Igor Thiago Alvin
Vieira,Wester Silva
Kochergin,Clavdia Nicolaevna
Medeiros,Danielle Souto de
Soares,Daniela Arruda
Louzado,José Andrade
Silva,Kelle Oliveira
Cortes,Matheus Lopes
Mistro,Sóstenes
Bezerra,Vanessa Moraes
Oliveira,Marcio Galvão
Comparison of cardiovascular risk calculators in patients with diabetes
author_facet Ribeiro,Luana Karem
Amorim,Welma Wildes
Cardoso,Igor Thiago Alvin
Vieira,Wester Silva
Kochergin,Clavdia Nicolaevna
Medeiros,Danielle Souto de
Soares,Daniela Arruda
Louzado,José Andrade
Silva,Kelle Oliveira
Cortes,Matheus Lopes
Mistro,Sóstenes
Bezerra,Vanessa Moraes
Oliveira,Marcio Galvão
author_sort Ribeiro,Luana Karem
title Comparison of cardiovascular risk calculators in patients with diabetes
title_short Comparison of cardiovascular risk calculators in patients with diabetes
title_full Comparison of cardiovascular risk calculators in patients with diabetes
title_fullStr Comparison of cardiovascular risk calculators in patients with diabetes
title_full_unstemmed Comparison of cardiovascular risk calculators in patients with diabetes
title_sort comparison of cardiovascular risk calculators in patients with diabetes
description SUMMARY OBJECTIVE: Cardiovascular risk stratification is an important clinical practice to estimate the severity of cardiovascular disease in patients with type 2 diabetes. This study aimed to compare the stratification of global cardiovascular risk with the specific risk stratification for patients with type 2 diabetes, seen at specialized outpatient clinics, and to evaluate possible differences in diagnoses and treatments. METHODS: A total of 122 patients with type 2 diabetes treated at two specialized outpatient clinics, from 2017 to 2019, were studied. The cardiovascular risk stratification calculators, global risk score, Cardiovascular Risk Stratification Calculator, and United Kingdom Prospective Diabetes Study-Risk Engine, were used to calculate the risk of death from cardiovascular disease. The agreement between these calculators was analyzed using the kappa index. The indications for the use of statins and acetylsalicylic acid for the group studied were evaluated according to the Brazilian Diabetes Society Guideline. RESULTS: There was a low degree of agreement among the three risk calculators. The global risk score calculator showed insignificant agreement with the Cardiovascular Risk Stratification Calculator (kappa=0.0816; p=0.0671). There was no agreement between the global risk score calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.099), or between the Cardiovascular Risk Stratification Calculator and United Kingdom Prospective Diabetes Study-Risk Engine (kappa=-0.0095). CONCLUSION: The substantial disagreements among the cardiovascular risk calculators may lead to different diagnoses and may consequently influence therapeutic strategies. The findings herein highlight the need for specific validated cardiovascular risk calculators for patients with DM2 that can reliably estimate risk in these individuals.
publisher Associação Médica Brasileira
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302021000300200
work_keys_str_mv AT ribeiroluanakarem comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT amorimwelmawildes comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT cardosoigorthiagoalvin comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT vieirawestersilva comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT kocherginclavdianicolaevna comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT medeirosdaniellesoutode comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT soaresdanielaarruda comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT louzadojoseandrade comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT silvakelleoliveira comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT cortesmatheuslopes comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT mistrosostenes comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT bezerravanessamoraes comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
AT oliveiramarciogalvao comparisonofcardiovascularriskcalculatorsinpatientswithdiabetes
_version_ 1756410109344350208